Local Mechanical Perturbation Provides an Effective Means to Regulate the Growth and Assembly of Functional Peptide Fibrils

• Published in: Small (Weinheim an der Bergstrasse, Germany) Germany), 2016-12, Vol.12 (46), p.6407-6415
• Main Authors: Karsai, Arpad, Slack, Teri Jo, Malekan, Hamed, Khoury, Fadi, Lin, Wei-Feng, Tran, Victoria, Cox, Daniel, Toney, Michael, Chen, Xi, Liu, Gang-yu
• Format: Article
• Language: English
• Subjects: Amyloid - chemistry; amyloid fibrils; Assembly; Atomic force microscopy; Formations; mechanical perturbation; Microscopy, Atomic Force; mucin 1 peptides; Mucin-1 - chemistry; Nanotechnology; Nucleation; Nuclei; Orientation; Peptides; Peptides - chemistry; Perturbation; self-assembly
• ISSN: 1613-6810; 1613-6829
• DOI: 10.1002/smll.201601657

Mucin 1 (MUC1) peptide fused with Q11 (MUC1‐Q11) having 35 residues has previously been shown to form amyloid fibrils. Using time‐dependent and high‐resolution atomic force microscopy (AFM) imaging, it is revealed that the formation of individual MUC1‐Q11 fibrils entails nucleation and extension at both ends. This process can be altered by local mechanical perturbations using AFM probes. This work reports two specific perturbations and outcomes. First, by increasing load while maintaining tip‐surface contact, the fibrils are cut during the scan due to shearing. Growth of fibrils occurs at the newly exposed termini, following similar mechanism of the MUC1‐Q11 nucleation growth. As a result, branched fibrils are seen on the surface whose orientation and length can be controlled by the nuclei orientation and reaction time. In contrast to the “one‐time‐cut”, fibrils can be continuously fragmented by modulation at sufficiently high amplitude. As a result, short and highly branched fibrils accumulate and pile on surfaces. Since the fibril formation and assembly of MUC1‐Q11 can be impacted by local mechanical force, this approach offers a nonchemical and label‐free means to control the presentation of MUC1 epitopes, and has promising application in MUC1 fibril‐based immunotherapy. New nuclei of MUC1‐Q11 amyloid are created by cutting fibrils along x‐axis in 23 nm periodicity. Growth and reassembly of fibrils occur at both ends of newly formed nuclei.